Under The Shadow Of Drug Price Reform, US Tax Policies Still Challenge Pharma

 
• By Jessica Merrill
  
Taxes
The US is considering a corporate tax increase that could impact pharma • Source: Alamy

More from Legislation

More from Pink Sheet